Request PDF on ResearchGate | On Jan 1, , S.D. Navaneethan and others published Inhibidores de la HMG CoA reductasa (estatinas) para pacientes en. Request PDF on ResearchGate | On Jan 1, , S.D. Navaneethan and others published Inhibidores de la HMG CoA reductasa (estatinas) para pacientes con. Los inhibidores de la enzima hepática HMG-CoA reductasa (estatinas), pueden indu- cir importantes reducciones en los niveles de colesterol plasmático y por.

Author: Jutaxe Sajas
Country: Mauritania
Language: English (Spanish)
Genre: Career
Published (Last): 19 January 2008
Pages: 497
PDF File Size: 18.14 Mb
ePub File Size: 17.86 Mb
ISBN: 159-6-98443-703-3
Downloads: 61270
Price: Free* [*Free Regsitration Required]
Uploader: Malrajas

Biochemical and Biophysical Research Communications 2: Effect of the bile acid sequestrant colesevelam on the pharmacokinetics of pioglitazone, repaglinide, estrogen estradiol, norethindrone, levothyroxine, and glyburide. El diltiazem puede causar un aumento en la Cmax en 3,6 veces y el ABC en 5 veces de la simvastatina y de 3,5 veces el ABC de lovastatina; efecto que no se evidencia en el caso de la pravastatina Lack of a clinically significant pharmacokinetic interaction between fenofibrate and pravastatin in healthy volunteers.

Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors when coadministered with everolimus. Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites. Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin. Different effects of itraconazole on the pharmacokinetics of fluvastatin and inhibodores.


There was a problem providing the content you requested

The pharmacologic and pharmacokinetic properties of this new statin are review in this article. Presumed interaction of fusidic acid with simvastatin. J Pharmacol Exp Ther. Of the interactions identified in patients on hypolipidemic drugs, Shitara Y, Sugiyama Y. De Wikipedia, la enciclopedia libre.

Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatina in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects. Enzymatic inhibition of CYP was the most common mechanism for these interactions.

HMG-CoA reductasa – Wikipedia, la enciclopedia libre

Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations. Atorvastatin does not alter the anticoagulant activity of warfarin. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin. Plasma concentration profiles of simvastatin 3-hydroxymethylglutaryl-coenzyme A reductase inhibitory activity in kidney transplant recipients with and without ciclosporin. J Clin Pharm Ther.

Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin injibidores. Different effects of St John’s wort on the pharmacokinetics of simvastatin and pravastatin.

Tratamiento de la hipertrigliceridemia: Rhabdomyolysis due to a combination of itraconazole and simvastatin. Rosuvastatin may cause inbibidores, nephrotoxicity, and hepatotoxicity, but these and other adverse reactions have not been shown to occur at higher rates with rosuvastatin compared to other statins when used at approved dosages. Effect of gemfibrozil on the pharmacokinetics of pioglitazone.


Estos efectos se deben posiblemente al efecto inhibidor de estos calcioantagonistas sobre la CYP3A4 Am J Cardiovasc Drugs. Harvengt C, Desager JP. N Engl J Med. Journal of Lipid Research 25 9: The following Mesh terms were used: Evaluation of the pharmacokinetic interaction between fluvastatin XL and cyclosporine in renal transplant recipients.

Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir. Rhabdomyolysis with simvastatin and nefazodone.

The interaction of fluvastatin and cyclosporin A in renal transplant patients. Eur J Clin Pharmacol. Comunicado de la FDA sobre la seguridad de los medicamentos: Bienvenido a siicsalud Contacto Inquietudes.

A lesson for everyone in drug-drug interactions. Oates E, Dzintars K.

Rhabdomyolysis and acute renal failure in a cardiac transplant recipient due to multiple drug interactions. Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics.

Rhabdomyolysis in association with simvastatin and amiodarone. Curr Med Res Opin. Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin.

Detecting drug interactions from adverse-event reports: Concomitant use of simvastatin and amiodarone resulting in severe rhabdomyolysis: Baycol withdrawn from market.